Eli Lilly grew revenue 48% while prices fell; can volume keep winning?
FROM THE WIRE · FINANCE.YAHOO.COM
Eli Lilly (NYSE:LLY) reports third-quarter results in about a week, and the split between volume and price matters more than the headline total. In the second quarter, revenue rose 48% to $23.0 billion on a 60% jump in the amount of medicine sold, while the price Lilly collected…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralLilly's third-quarter results are due in about a week and the volume-price mix matters for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01In the second quarter revenue rose 48% to $23.0 billion.
- 02Volume sold rose 60% while the price collected per unit fell 13%.
- 03Mounjaro brought in $9.9 billion last quarter, up 91%.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets